Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge

SIMPLE SUMMARY: The management and treatment of patients with inflammatory bowel diseases after a diagnosis of malignancy represents a challenge for physicians, since their most common therapy, such as biologics and immunosuppressants, should be discontinued for 2–5 years after the end of cancer tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferretti, Francesca, Cannatelli, Rosanna, Maconi, Giovanni, Ardizzone, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856548/
https://www.ncbi.nlm.nih.gov/pubmed/36672491
http://dx.doi.org/10.3390/cancers15020542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856548/
https://www.ncbi.nlm.nih.gov/pubmed/36672491
http://dx.doi.org/10.3390/cancers15020542

Ejemplares similares